| Title : Prevention of suxamethonium-induced changes in serum potassium concentration by hexafluorenium. Is their combined use justified? - Radnay_1979_Br.J.Anaesth_51_447 |
| Author(s) : Radnay PA , Badola RP , Dalsania A , El-Gaweet EI , Duncalf D |
| Ref : British Journal of Anaesthesia , 51 :447 , 1979 |
|
Abstract :
Sixty patients, none of whom was suffering from renal failure, received neurolept anaesthesia. They were divided into six groups of 10 patients each. Groups I and IV, II and V, and III and VI were given suxamethonium 0.2, 0.6 and 1.0 mg kg-1 respectively. Groups IV-VI were pretreated with hexafluorenium 0.3 mg kg-1. The serum potassium concentration decreased significantly after the induction of anaesthesia and also following the administration of hexafluorenium. Neither suxamethonium 0.2 mg nor 0.6 mg kg-1 with or without hexafluorenium restored the potassium concentration to the control value. Suxamethonium 1.0 mg kg-1 alone caused the serum potassium to increase to values greater than control; hexafluorenium attenuated this effect. The combination of hexafluorenium and suxamethonium may be of benefit in patients who are anephric or are in chronic renal failure. |
| PubMedSearch : Radnay_1979_Br.J.Anaesth_51_447 |
| PubMedID: 444345 |
| Inhibitor | Mylaxen |
Radnay PA, Badola RP, Dalsania A, El-Gaweet EI, Duncalf D (1979)
Prevention of suxamethonium-induced changes in serum potassium concentration by hexafluorenium. Is their combined use justified?
British Journal of Anaesthesia
51 :447
Radnay PA, Badola RP, Dalsania A, El-Gaweet EI, Duncalf D (1979)
British Journal of Anaesthesia
51 :447